Eli Lilly and Co (LLY)
776.75
-4.35
(-0.56%)
USD |
NYSE |
May 01, 16:00
777.12
+0.37
(+0.05%)
After-Hours: 20:00
Eli Lilly Shareholders Equity (Quarterly): 12.81B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.81B |
December 31, 2023 | 10.77B |
September 30, 2023 | 11.22B |
June 30, 2023 | 11.06B |
March 31, 2023 | 11.19B |
December 31, 2022 | 10.65B |
September 30, 2022 | 10.07B |
June 30, 2022 | 8.545B |
March 31, 2022 | 9.331B |
December 31, 2021 | 8.979B |
September 30, 2021 | 7.757B |
June 30, 2021 | 6.444B |
March 31, 2021 | 6.899B |
December 31, 2020 | 5.642B |
September 30, 2020 | 4.827B |
June 30, 2020 | 4.093B |
March 31, 2020 | 3.079B |
December 31, 2019 | 2.607B |
September 30, 2019 | 3.382B |
June 30, 2019 | 2.780B |
March 31, 2019 | 2.480B |
December 31, 2018 | 9.829B |
September 30, 2018 | 13.08B |
June 30, 2018 | 11.56B |
March 31, 2018 | 14.53B |
Date | Value |
---|---|
December 31, 2017 | 11.59B |
September 30, 2017 | 14.89B |
June 30, 2017 | 14.10B |
March 31, 2017 | 14.03B |
December 31, 2016 | 14.01B |
September 30, 2016 | 15.59B |
June 30, 2016 | 14.64B |
March 31, 2016 | 15.01B |
December 31, 2015 | 14.57B |
September 30, 2015 | 15.22B |
June 30, 2015 | 14.67B |
March 31, 2015 | 14.92B |
December 31, 2014 | 15.37B |
September 30, 2014 | 17.67B |
June 30, 2014 | 17.98B |
March 31, 2014 | 18.34B |
December 31, 2013 | 17.63B |
September 30, 2013 | 16.89B |
June 30, 2013 | 15.23B |
March 31, 2013 | 14.95B |
December 31, 2012 | 14.77B |
September 30, 2012 | 16.06B |
June 30, 2012 | 14.31B |
March 31, 2012 | 14.83B |
December 31, 2011 | 13.54B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.607B
Minimum
Dec 2019
12.81B
Maximum
Mar 2024
7.607B
Average
8.151B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 6.232B |
Madrigal Pharmaceuticals Inc | 405.33M |
Vertex Pharmaceuticals Inc | 17.58B |
Viking Therapeutics Inc | 933.89M |
Moderna Inc | 13.85B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 63.94B |
Total Liabilities (Quarterly) | 51.05B |
Debt to Equity Ratio | 2.046 |
Current Ratio | 1.354 |
Net Debt Paydown Yield | -0.27% |